Therapeutic Options for Lymphangioleiomyomatosis (LAM): Where We Are and Where We Are Going

F1000 Medicine Reports
doi 10.3410/m1-93
Full Text
Abstract

Available in full text

Date
Authors
Publisher

F1000 Research Ltd

Related search

Sequence Analysis: Where Are We, Where Are We Going?

Sequence Analysis and Related Approaches
2018English

Where Are We Going ... ?

Scandinavian Journal of Occupational Therapy
EnvironmentalPublic HealthOccupational Health
2014English

Where Are We Going?

American Journal of Orthodontics and Dentofacial Orthopedics
Orthodontics
2015English

Molecular Targeted Agents--Where We Are and Where We Are Going

Chinese Journal of Cancer
2013English

Antisperm Contraceptive Vaccines: Where We Are and Where We Are Going?

American Journal of Reproductive Immunology
GynecologyReproductive MedicineImmunologyObstetricsAllergy
2011English

Pulmonary Arterial Hypertension: Where Are We and Where Are We Going?

Advances in Pulmonary Hypertension
2009English

Where Have We Been and Where Are We Going?

1998English

Understanding Diabetic Teratogenesis: Where Are We Now and Where Are We Going?

Birth Defects Research Part A - Clinical and Molecular Teratology
Child HealthPediatricsPerinatologyMedicineDevelopmental BiologyEmbryology
2010English

Cytologic-Histologic Correlation: Where Are We Now, and Where Are We Going?

Cancer cytopathology
Cancer ResearchOncology
2018English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2026 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy